Predictors and noninvasive identification of severe liver fibrosis in patients with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 52, Issue 2, 2007, Pages 582-588

  Metwally, Mohamed A ^a   Zein, Claudia O ^a   Zein, Nizar N ^a,b  

^a MAYO CLINIC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Diagnosis; Multivariate analysis; Predictors

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT IDENTIFICATION; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS;

ADULT; AGED; ASPARTATE AMINOTRANSFERASES; BLOOD TRANSFUSION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 33846798388     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9366-z     Document Type: Article

References (24)

1. WHO/Viral Hepatitis Prevention Board (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6:35-47
2. Alter MJ, Kruszon-Moran D, Nainan OV, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562
3. Alter MJ (1995) Epidemiology of hepatitis C in the West. Semin Liver Dis 15:5-14
4. Terrault N, Wright T (1995) Interferon and hepatitis C virus infection. N Engl J Med 332:1509-1511
5. Di Bisceglie AM (2000) Natural history of hepatitis C: its impact on clinical management. Hepatology 31:1014-1018
6. Kiyosawa K, Sodeyama T, Tanaka E, et al. (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675
7. Poynard T, McHutchison J, Goodman Z, Ling MH, Albrecht J (2000) Is an "a la carte" combination interferon alfa-2b plus ribavirinregimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group. Hepatology 31:211-218
8. Khan MH, Thomas L, Byth K, et al. (1998) How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J Gastroenterol Hepatol 13:419-426
9. Hourigan LF, Macdonald GA, Purdie D, et al. (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29:1215-1219
10. Bonacini M, Hadi G, Govindarajan S, Lindsay KL (1997) Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 92:1302-1304
11. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K (2001) The role of liver biopsy in chronic hepatitis C. Hepatology 33:196-200
12. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, MULTIVIRC Group (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357:1069-1075
13. Wannamethee G, Shaper AG (1988) Men who do not drink: a report from the British Regional Heart Study. Int J Epidemiol 17:307-316
14. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH (1996) Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 125:634-639
15. The French METAVIR Cooperative Study Group (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20:15-20
16. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293
17. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
18. Kamath PS, Wiesner RH, Malinchoc M, et al. (2001) A model to predict survival in patientswith end-stage liver disease. Hepatology 33:464-470
19. Lechner K, Niessner H, Thaler E (1977) Coagulation abnormalities in liver disease. Semin Thromb Hemost 4:40-56
20. Aoki Y, Hirai K, Tanikawa K (1993) Mechanism of thrombocytopenia in liver cirrhosis: kinetics of indium-111 tropolone labelled platelets. Eur J Nucl Med 20:123-129
21. de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M (1991) Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease. Clin Lab Haematol 13:127-135
22. Sheth SG, Flamm SL, Gordon FD, Chopra S (1998) AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 93:44-48
23. De Maria N, Colantoni A, Friedlander L, et al. (2000) The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 95:3529-3536
24. Gordon SC, Elloway RS, Long JC, Dmuchowski CF (1993) The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology 18:1338-1343